Omicron may have FDA rethinking vaccine strategy for kids under 5 – Ars Technica
Enlarge
/ A child getting a vaccination on February 19, 2021, in Bonn, Germany.
Covid-19 Coverage
View more stories
The Food and Drug Administration may be reconsidering its criteria for authorizing COVID-19 vaccine doses for children under age five, according to Scott Gottlieb, a former FDA commissioner and a current board member of vaccine-maker Pfizer. This opens the possibility that vaccine-ineligible youngsters could get protection from severe COVID-19 sooner than anticipated.
In an interview Sunday, Dr. Gottlieb told CBS's Face the Nation that he sensed a shift in federal health officials' thinking on the younger group. "And I'm hopeful that you could see some movement on trying to entertain that application earlier," he said. "Ultimately...